Screening of the Prime bioactive compounds from Aloe vera as potential anti-proliferative agents targeting DNA
Aloe vera extract and its bioactive compounds possess anti-proliferative properties against cancer cells. However, no detailed molecular mechanism of action studies has been reported. We have now employed a computational approach to scrutinize the molecular mechanism of lead bioactive compounds from...
Gespeichert in:
Veröffentlicht in: | Computers in biology and medicine 2022-02, Vol.141, p.105052-105052, Article 105052 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Aloe vera extract and its bioactive compounds possess anti-proliferative properties against cancer cells. However, no detailed molecular mechanism of action studies has been reported. We have now employed a computational approach to scrutinize the molecular mechanism of lead bioactive compounds from Aloe vera that potentially inhibit DNA synthesis.
Initially, the anti-proliferative activity of Aloe vera extract was examined in human breast cancer cells (in vitro/in vivo). Later on, computational screening of bioactive compounds from Aloe vera targeting DNA was performed by molecular docking and molecular dynamics simulation.
In-vitro and in-vivo studies confirm that Aloe vera extract effectively suppresses the growth of breast cancer cells without significant cytotoxicity towards non-cancerous normal immortal cells. Computational screening predicts that growth suppression may be due to the presence of DNA intercalating bioactive compounds (riboflavin, daidzin, aloin, etc.) contained in Aloe vera. MM/PBSA calculation showed that riboflavin has a higher binding affinity at the DNA binding sites compared to standard drug daunorubicin.
These observations support the hypothesis that riboflavin may be exploited as an anti-proliferative DNA intercalating agent to prevent cancer and is worthy of testing for the management of cancer by performing more extensive pre-clinical and if validated clinical trials.
[Display omitted]
•Aloe vera has anti-proliferative activity on breast cancer cells without significant cytotoxicity toward normal cells.•Computational screening (Molecular docking and MD simulation) of anti-proliferative (DNA targeting) agents from Aloe vera.•MM/PBSA calculation has been performed to determined binding energy between DNA and lead bioactive compounds from Aloe vera.•Molecular dynamic simulation in explicit solvent suggests that Riboflavin and Daidzin form a stable complex with DNA.•DNA, ligands and system solvent shows effective interaction network throughout the whole MD simulation. |
---|---|
ISSN: | 0010-4825 1879-0534 |
DOI: | 10.1016/j.compbiomed.2021.105052 |